Skip to Main Content

Paper Details

Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.
JAMA Neurol
35
2020
APOE, Alzheimer, Alzheimer Disease, Alzheimer disease, Alzheimer's, Asymptomatic Alzheimer Disease, Brain Amyloidosis, Cognitive Decline, Individuals, Participants, RBFOX1, RBFOX1 protein, RNA, amyloid, amyloidosis, brain amyloidosis, cognitive decline, mild cognitive impairment, novel locus, participants, women
Author NameAffiliation
Logan DumitrescuVanderbilt University Medical Center
Logan DumitrescuVanderbilt Genetics Institute, Vanderbilt University Medical Center
David B GoldsteinColumbia University Medical Center
David B GoldsteinTaub Institute for Research on Alzheimer's Disease and The Aging Brain, Columbia University Medical Center
David B GoldsteinThe New York Presbyterian Hospital
David B GoldsteinColumbia University Medical Center
David B GoldsteinThe New York Presbyterian Hospital
David B GoldsteinTaub Institute for Research on Alzheimer's Disease and The Aging Brain, Columbia University Medical Center
Andrew J SaykinCenter for Neuroimaging, Indiana University
Andrew J SaykinIndiana University
Andrew J SaykinCenter for Neuroimaging, Indiana University
Andrew J SaykinIndiana University
William J JagustHelen Wills Neuroscience Institute, University of California berkeley
Marilyn AlbertJohns Hopkins University School of Medicine
Hyun-Sik YangMassachusetts General Hospital
Hyun-Sik YangCenter for Alzheimer Research and Treatment, Brigham and Women's Hospital
Keith A JohnsonMassachusetts General Hospital
Keith A JohnsonCenter for Alzheimer Research and Treatment, Brigham and Women's Hospital
Paul S AisenAlzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California
Reisa A SperlingMassachusetts General Hospital
Reisa A SperlingCenter for Alzheimer Research and Treatment, Brigham and Women's Hospital
Philip L De JagerColumbia University Medical Center
Philip L De JagerBroad Institute
Philip L De JagerCenter for Translational and Computational Neuroimmunology, Columbia University Medical Center
Philip L De JagerTaub Institute for Research on Alzheimer's Disease and The Aging Brain, Columbia University Medical Center
Philip L De JagerThe New York Presbyterian Hospital
Philip L De JagerColumbia University Medical Center
Philip L De JagerThe New York Presbyterian Hospital
Philip L De JagerTaub Institute for Research on Alzheimer's Disease and The Aging Brain, Columbia University Medical Center
Philip L De JagerCenter for Translational and Computational Neuroimmunology, Columbia University Medical Center
Philip L De JagerBroad Institute
David A BennettRush University Medical Center
David A BennettRush University Medical Center
Badri N VardarajanColumbia University Medical Center
Badri N VardarajanThe New York Presbyterian Hospital
Badri N VardarajanTaub Institute for Research on Alzheimer's Disease and The Aging Brain, Columbia University Medical Center
Badri N VardarajanThe Institute for Genomic Medicine, Columbia University Medical Center
  • 1 - 37

Datasets